世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000030876

自動・閉鎖型細胞調整システム市場の市場規模・シェア・動向分析レポート:ワークフロー別、タイプ別、規模別、およびセグメント予測(2021年〜2028年)

Grand View Research Inc.

Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation, Expansion), By Type (Non-stem Cell, Stem Cell), By Scale, And Segment Forecasts, 2021 - 2028

発刊日 2021/11/12

言語英語

体裁PDF/136ページ

ライセンス/価格136ページ

0000030876

Single
Multiuser
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

自動・閉鎖型細胞調整システム市場の成長と動向

自動・閉鎖型細胞調整システムの世界市場は、予測期間中に21.7%のCAGRを記録し、2028年までに29億4,000万米ドルに達すると予想されています。市場のプレーヤーは、細胞治療製品の開発プロセスを加速するための実行可能な戦略として、自動化プロセスシステムを導入するために多額の投資を行っており、それが市場成長の原動力となっています。

GMP製造施設の拡大は、商業活動における自動化プロセスの導入をさらに後押ししています。また、単回使用の使い捨てチューブセットやバッグは応用範囲が広いため、治療研究開発の自動化が促進されます。さらに、主要企業は製造ラボに自動化技術を効果的に導入するための戦略を立てており、これが収益の拡大につながっています。

COVID-19の症例が急速に増加していることが、市場の成長に重要な役割を果たすと予想されています。パンデミックの影響で、自動化技術への注目が高まっています。さらに、企業はCOVID-19に対抗するための先進的な治療法や再生医療の開発を目指して、資金調達を重視しています。また、幹細胞治療、ナチュラルキラー細胞治療、エクソソームなどの新しい治療法の開発にも力を入れています。

自動・閉鎖型細胞調整システム市場レポートのハイライト

  • 2020年の世界市場では、細胞拡張ワークフローセグメントが最大の収益シェアを占めました。高出力の収量を達成することへの関心が高まっていることが、このセグメントの高い収益シェアにつながっています。
  • 幹細胞治療の研究開発プログラムが増加していることから、細胞分離ワークフロー分野は、予測期間中に最も速いCAGRを記録すると推定されます。
  • 自動化されたアフェレーシスと凍結保存のワークフローは、細胞治療のための保存と選別の重要性が増していることから、予測期間中にかなりの成長率を記録すると予想されます。
  • 2020年には非幹細胞療法のセグメントが市場を支配し、予測期間中は安定したCAGRでさらに拡大すると考えられます。CAR T療法の成功は、このセグメントの主要な推進力の一つです。
  • 2020年には、新薬・治療法開発のための研究・イノベーション活動の増加により、プレコマーシャル/R&D規模製造のセグメントが最大の収益シェアを獲得しました。
  • 北アメリカは2020年に最も収益の高い地域となりました。これは、この地域で承認された治療法が多数存在することにより、市場のプレーヤーが研究開発プログラムへの投資を増やしているためです。
  • 企業は、より高い市場シェアを獲得するために、提携や協力などの戦略的な取り組みを行っています。例えば、Fresenius Kabiform社は2021年1月、Bio-Techne社との合弁会社を設立し、スケーラブルで汎用性の高い治療薬製造プラットフォームを開発する「ScaleReady」を発売しました

レポート詳細

目次

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 Gvr's Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details Of Primary Research
1.5 Information or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1. Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.8 Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:

Chapter 2 Executive Summary
2.1 Competition Milieu
2.2 Segment Outlook
2.3 Market Summary, 2020 (USD Million)

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation

Chapter 4 Industry Outlook
4.1 Parent Market Lineage
4.2 Ancillary Market Lineage
4.3 Market Dynamics
4.3.1 Market driver analysis
4.3.1.1 Rising Emphasis On Regenerative Medicines And Cell Therapies
4.3.1.2 Operational Superiority Of Automated Systems Over Manual Processing
4.3.1.3 Extensively Increasing Technological Advancements
4.3.2 Market Restraint Analysis
4.3.2.1 Biological Variations Associated With Different Therapies
4.3.3 Market opportunity analysis
4.3.3.1 Growing Fund-Raising Activities By Companies For New Technology Development
4.3.3.2 Research Activitis And Product Innovations
4.3.4 Market Challenge Analysis
4.3.4.1 Complicated Process Of Automation
4.4 SWOT Analysis; by Factor (Political & Legal, Economic and Technological)
4.5 Porter's Five Forces Analysis
4.6 Major Deals and Strategic Alliances Analysis
4.6.1 Mergers And Acquisitions
4.6.2 Technological Collaborations And Partnerships
4.6.3 Product Approvals And Launches
4.7 Covid-19 Impact Analysis
4.7.1 Challenge Analysis
4.7.2 Opportunity Analysis
4.7.3 Key Developments And Activities

Chapter 5 Competitive Analysis
5.1 Company Mapping
5.2 List of Potential End Users
5.3 List of Emerging Players
5.4 Market Differentiators
5.5 Competitive Dashboard Analysis
5.6 Regional Network Map

Chapter 6 Workflow Business Analysis
6.1 Automated and Closed Cell Therapy Processing Systems Market: Workflow Movement Analysis
6.2 Separation
6.2.1 Separation Market Estimates And Forecast, 2017 - 2028 (USD Million)
6.3 Expansion
6.3.1 Expansion market Estimates And Forecast, 2017 - 2028 (USD Million)
6.4 Apheresis
6.4.1 Apheresis market Estimates And Forecast, 2017 - 2028 (USD Million)
6.5 Fill-Finish
6.5.1 Fill-Finish Market Estimates And Forecast, 2017 - 2028 (USD Million)
6.6 Cryopreservation
6.6.1 Cryopreservation market Estimates And Forecast, 2017 - 2028 (USD Million)
6.7 Others
6.7.1 Others Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 7 Type Business Analysis
7.1 Automated and Closed Cell Therapy Processing Systems Market: Type Movement Analysis
7.2 Stem Cell Therapy
7.2.1 Stem Cell Therapy Market Estimates And Forecast, 2017 - 2028 (USD Million)
7.3 Non-Stem Cell Therapy
7.3.1 Non-Stem Cell Therapy Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 8 Scale Business Analysis
8.1 Automated and Closed Cell Therapy Processing Systems Market: Scale Movement Analysis
8.2 Pre-Commercial/R&D Scale Manufacturing
8.2.1 Pre-Commercial/R&D Scale Manufacturing Market Estimates And Forecast, 2017 - 2028 (USD Million)
8.3 Commercial Scale Manufacturing
8.3.1 Commercial Scale Manufacturing Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 9 Regional Business Analysis
9.1 Automated and Closed Cell Therapy Processing Systems Market: Regional Movement Analysis
9.2 North America
9.2.1 North America Automated And Closed Cell Therapy Processing Sysytems Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.2.2.2 U.S. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.2.2.3 U.S. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.2.3 Canada
9.2.3.1 Canada Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.2.3.2 Canada Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.2.3.3 Canada Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.3 Europe
9.3.1 Europe Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.3.2 Germany
9.3.2.1 Germany Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.3.2.2 Germany Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.3.2.3 Germany Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.3.3 U.K.
9.3.3.1 U.K. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.3.3.2 U.K. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.3.3.3 U.K. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.3.4 France
9.3.4.1 France Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.3.4.2 France Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.3.4.3 France Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.3.5 Italy
9.3.5.1 Italy Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.3.5.2 Italy Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.3.5.3 Italy Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.3.6 Spain
9.3.6.1 Spain Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.3.6.2 Spain Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.3.6.3 Spain Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific Automated And Closed Cell Therapy Processing Systems Market estimates And Forecast, 2017 - 2028 (USD Million)
9.4.2 Japan
9.4.2.1 Japan Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.4.2.2 Japan Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.4.2.3 Japan Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.4.3 China
9.4.3.1 China Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.4.3.2 China Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.4.3.3 China Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.4.4 India
9.4.4.1 India Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.4.4.2 India Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.4.4.3 India Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.4.5 South Korea
9.4.5.1 South Korea Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.4.5.2 South Korea Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.4.5.3 South Korea Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.4.6 Australia
9.4.6.1 Australia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.4.6.2 Australia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.4.6.3 Australia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.5 Latin America
9.5.1 Latin America automated And Closed Cell Therapy Processing Systems Market estimates And Forecast, 2017 - 2028 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.5.2.2 Brazil Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.5.2.3 Brazil Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.5.3.2 Mexico Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.5.3.3 Mexico Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.6 Middle East & Africa
9.6.1 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.6.2.2 South Africa Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.6.2.3 South Africa Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.6.3.2 Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.6.3.3 Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
9.6.4 UAE
9.6.4.1 UAE Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
9.6.4.2 UAE Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
9.6.4.3 UAE Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)

Chapter 10 Company Profiles
10.1 Strategy Framework
10.2 Market Participation Categorization
10.3 Company Profiles
10.3.1 MILTENYI BIOTEC
10.3.1.1 Company Overview
10.3.1.2 Product Benchmarking
10.3.1.3 Strategic Initiatives
10.3.2 LONZA
10.3.2.1 Company Overview
10.3.2.2 Financial Performance
10.3.2.3 Product Benchmarking
10.3.2.4 Strategic Initiatives
10.3.3 FRESENIUS KABI
10.3.3.1 Company Overview
10.3.3.2 Financial Performance
10.3.3.3 Product Benchmarking
10.3.3.4 Startegic Initiatives
10.3.4 CYTIVA (DANAHER CORPORATION)
10.3.4.1 Company Overview
10.3.4.2 Financial Performance
10.3.4.3 Product Benchmarking
10.3.4.4 Startegic Initiatives
10.3.5 BIOSPHERIX, LTD.
10.3.5.1 Company Overview
10.3.5.2 Product Benchmarking
10.3.5.3 Startegic Initiatives
10.3.6 TERUMO CORPORATION
10.3.6.1 Company Overview
10.3.6.2 Financial Performance
10.3.6.3 Product Benchmarking
10.3.6.4 Startegic Initiatives
10.3.7 SARTORIUS AG
10.3.7.1 Company Overview
10.3.7.2 Financial Performance
10.3.7.3 Product Benchmarking
10.3.7.4 Startegic Initiatives
10.3.8 THERMOGENESIS HOLDINGS, INC.
10.3.8.1 Company Overview
10.3.8.2 Financial Performance
10.3.8.3 Product Benchmarking
10.3.8.4 Startegic Initiatives
10.3.9 CELLARES INC.
10.3.9.1 Company Overview
10.3.9.2 Product Benchmarking
10.3.9.3 Startegic Initiatives
10.3.10 THERMO FISHER SCIENTIFIC, INC.
10.3.10.1 Company Overview
10.3.10.2 Financial Performance
10.3.10.3 Product Benchmarking
10.3.10.4 Startegic Initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of automated and closed cell therapy processing systems manufacturers
Table 3 List of potential end-users
Table 4 List of emerging players
Table 5 List of market differentiators
Table 6 Competitive dashboard analysis
Table 7 Regional network map
Table 8 North America automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 9 North America automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 10 North America automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 11 U.S. automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 12 U.S. automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 13 U.S. automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 14 Canada automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 15 Canada automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 16 Canada automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 17 Europe automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 18 Europe automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 19 Europe automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 20 Germany automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 21 Germany automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 22 Germany automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 23 U.K. automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 24 U.K. automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 25 U.K. automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 26 Italy automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 27 Italy automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 28 Italy automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 29 Spain automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 30 Spain automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 31 Spain automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 32 France automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 33 France automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 34 France America automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 35 Asia Pacific automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 36 Asia Pacific automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 37 Asia Pacific automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 38 China automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 39 China automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 40 China automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 41 Japan automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 42 Japan automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 43 Japan automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 44 India automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 45 India automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 46 India automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 47 South Korea automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 48 South Korea automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 49 South Korea automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 50 Australia automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 51 Australia automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 52 Australia automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 53 Latin America automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 54 Latin America automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 55 Latin America automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 56 Brazil automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 57 Brazil automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 58 Brazil automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 59 Mexico automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 60 Mexico automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 61 Mexico automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 62 MEA automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 63 MEA automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 64 MEA automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 65 South Africa automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 66 South Africa automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 67 South Africa automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 68 Saudi Arabia automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 69 Saudi Arabia automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 70 Saudi Arabia automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
Table 71 UAE automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
Table 72 UAE automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
Table 73 UAE automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Classification of companies
Fig. 9 Automated and closed cell therapy processing systems market snapshot, 2020 (USD Million)
Fig. 10 Automated and Closed Cell Therapy Processing System Market segmentation
Fig. 11 Market driver impact
Fig. 12 Market restraint impact
Fig. 13 Automated and closed cell therapy processing systems market SWOT analysis
Fig. 14 Automated and closed cell therapy processing systems market Porter's five forces analysis
Fig. 15 Automated and closed cell therapy processing systems market : Workflow outlook and key takeaways
Fig. 16 Automated and closed cell therapy processing systems market : Workflow movement analysis
Fig. 17 Separation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 18 Expansion market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 19 Apheres is market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 20 Fill-Finish market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 21 Cryopreservation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 22 Others market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 23 Automated and closed cell therapy processing systems market : Type outlook and key takeaways
Fig. 24 Automated and closed cell therapy processing systems market : Type movement analysis
Fig. 25 Stem cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 26 Non-stem cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 27 Automated and closed cell therapy processing systems market : Scaleoutlook and key takeaways
Fig. 28 Automated and closed cell therapy processing systems market : Scale movement analysis
Fig. 29 Pre-commercial/ R&D scale manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 30 Commercial scale manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 31 Automated and closed cell therapy processing systems market : Regional outlook and key takeaways
Fig. 32 Automated and closed cell therapy processing systems market : Regional movement analysis
Fig. 33 North America automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 34 U.S. automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 35 Canada cell and gene therapy manufacturing) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 36 Europe automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 37 Germany automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 38 U.K. automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 39 France automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 40 Italy automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 41 Spain automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 42 Asia Pacific automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 43 Japan automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 44 China automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 45 India automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 46 South Korea automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 47 Australia automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 48 Latin America automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 49 Brazil automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 50 Mexico automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 51 Middle East & Africa automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 52 South Africa automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 53 Saudi Arabia automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 54 UAE automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 55 Strategy framework
Fig. 56 Market participation categorization

この商品のレポートナンバー

0000030876

TOP